1. Gliosarcoma with PNET features mimicking a metastatic neuroendocrine carcinoma: A diagnostic dilemma.
- Author
-
McGahan BG, Toop N, Ward S, Jones D, Kobalka PJ, Palmer JD, and Elder JB
- Subjects
- Aged, Biomarkers analysis, Brain Neoplasms diagnosis, Brain Neoplasms genetics, Carcinoma, Neuroendocrine diagnosis, Diagnosis, Differential, Gliosarcoma diagnosis, Gliosarcoma genetics, Humans, Male, Mutation, PTEN Phosphohydrolase genetics, Telomerase genetics, Tumor Suppressor Protein p53 genetics, Brain Neoplasms pathology, Gliosarcoma pathology
- Abstract
Objective: Gliosarcomas (GS) comprise ~ 2 - 8% of glioblastomas and are associated with a similar poor prognosis. GS have rarely been found with a primitive neuroectodermal component (PNET). We present a case of gliosarcoma with PNET features (GS-PNET) that mimicked a neuroendocrine carcinoma on initial biopsy., Materials and Methods: A 68-year-old male presented with 2 weeks of increasing headaches and difficulties with reading, writing, and word-finding. He was found to have a left-sided parieto-occipital heterogeneously enhancing mass., Results: Pathologic analysis after surgical resection initially diagnosed a poorly differentiated carcinoma with neuroendocrine features, and adjuvant therapy was guided by this diagnosis as well as systemic imaging, which was suggestive of gastrointestinal primary malignancy with central nervous system (CNS) metastasis. Subsequent progression and re-resection established a diagnosis of GS with PNET component. Genomic profiling showed shared PTEN , TERT promotor, and TP53 mutations in the original and recurrent tumors., Conclusion: There have only been 5 previously reported cases of GS-PNET, to our knowledge, with this case representing the first with comprehensive molecular profiling. The case also highlights the importance of further work-up of presumed metastatic carcinoma with indeterminate immunostaining and/or suspected non-epithelioid component.
- Published
- 2021
- Full Text
- View/download PDF